0,1
"3.1.2.3	
Methods of kidney preservation: static and dynamic preservation
Whichever method is used, cold storage is critical. The use of cold preservation as a therapeutic window 
to deliver pharmacological or gene therapy treatments could, from an investigational point of view, improve 
both short- and long-term graft outcomes [43]. Cooling reduces the metabolic rate of biological tissue 
minimising continuous cellular processes that lead to depletion of ATP and accumulation of metabolic 
products. Reperfusion with oxygenated blood invokes ischaemia-reperfusion injury. Hypothermic perfusion 
does not enable normal cellular metabolic function or prevent depletion of energy stores [44]; however, it 
prevents the deleterious effects of simple cooling, especially in the setting of prolonged warm-ischaemic time 
in uncontrolled DCD donors. Two meta-analyses suggest that hypothermic machine perfusion (HMP) reduces 
DGF compared with static cold storage [45, 46]. Outcomes for primary non-function (PNF) are less clear, but 
one meta-analysis limited to high quality studies suggests a reduction in PNF rates with HMP [46]. A Cochrane 
systematic review and meta-analysis showed that HMP reduced the risk of DGF when compared to static cold 
storage (CS) for kidneys from both DCD and DBD donors [47].",
Recommendations,Strength rating
"Use either University of Wisconsin or histidine tryptophane ketoglutarate preservation 
solutions for cold storage.",Strong
"Use Celsior or Marshallâ€™s solution for cold storage if University of Wisconsin or histidine 
tryptophane ketoglutarate solutions are not available.",Strong
